Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

cGMP Influenza Vaccine Master and Working Seed Lot Production

Active

Federal

Response Deadline10/30/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda DcmaView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Washington, DC, 20024, USA

Set-Aside

NONE

Documents

This scope was carved out of 75A50126R00001_RFP_NPIVS_27.

The full solicitation package (19 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 17

subcontract

Response DeadlineOct 30

Submission deadline

Response Deadline

10/30/2026, 09:00:00 PM UTCin 2 months

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and quality testing of master and working viral seed lots for influenza vaccines under current Good Manufacturing Practice (cGMP) standards.

Similar Contracts

Same NAICS industry code

APPLICATOR, SILVER NITR

Solicitation # SPE2DP-26-T-4696

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FLUORESCEIN SODIUM OPH

Solicitation # SPE2DP-26-T-4702

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

GENTAMYCIN SULFATE

Solicitation # SPE2DP-26-T-4700

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ALBUTEROL SULFATE INHA

Solicitation # SPE2DP-26-T-4692

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECT

Solicitation # SPE2DP-26-T-4697

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-26-T-4703

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CETIRIZINE HYDROCHLORI

Solicitation # SPE2DP-26-T-4699

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Coagulation Analyzer System

Solicitation # FA860126Q0136SS

FA8601 Aflcmc Pzio

POSTED

DEADLINE

6505--VALL Iodine Isotope IDIQ

Solicitation # 36C26226Q1380

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

AMOXICILLIN AND CLAVUL

Solicitation # SPE2DP-26-T-4686

This contract is for the procurement of Amoxicillin and Clavulanate Potassium for oral suspension, USP, 600mg/42.9mg per 5ml in 125ml bottles. The order consists of two bottles under solicitation number SPE2DP-26-T-4686, with a required delivery date of August 20, 2026, and a delivery timeframe of 20 days. The product is regulated by the FDA and must be stored as a dry powder at controlled room temperature, requiring refrigeration after reconstitution. The agreement specifies a non-extendable shelf life of 24 months and mandates strict adherence to Medical Marking Standard No. 1 and DLA packaging requirements. Delivery is set as FOB Destination to the Medical Logistics unit at Fort Bragg, North Carolina. Approved manufacturers include Teva Pharmaceuticals USA and Sandoz Inc. All shipments must be sent via traceable means, excluding parcel post, and must comply with specific military packaging and marking standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MECLIZINE HYDROCHLORID

Solicitation # SPE2DP-26-T-4684

This contract is for the procurement of Meclizine Hydrochloride Tablets, USP, containing 25 milligrams of the active ingredient. The order consists of two bottles, with each bottle containing 1,000 tablets. The product is regulated by the FDA and must be stored at controlled room temperature between 20 and 25 degrees Celsius. The tablets have a total shelf life of 24 months, with a requirement that at least 21 months of shelf life remain upon receipt by the government. Packaging must adhere to commercial standards and Medical Marking Standard No. 1, ensuring items are sealed and protected from damage during transit. Delivery is set for FOB destination to the Medical Logistics activity at Fort Bragg, North Carolina, with a required delivery date of August 19, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Eyelid Cleanser Wipes (Pharmaceutical-Grade Pre-Moistened Pads)

National Cmop Office (36C770)

POSTED

DEADLINE

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

Regulatory and Quality Compliance Support

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Timely Payment Compliance for Small Business Subcontractors

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Subcontracting Plan Development and Reporting

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Cold Chain Storage and Distribution Services

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Candidate Influenza Vaccine Virus (CVV) Development

Research and Development in Biotechnology

POSTED

DEADLINE

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

BARDA is seeking contractors to support the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The selected providers will be responsible for furnishing all necessary personnel, materials, and facilities to produce vaccines, antigens, and adjuvants for pandemic preparedness and public health emergencies. This includes generating and submitting critical analytical, clinical, and manufacturing data to the FDA to ensure rapid regulatory decisions and manufacturing readiness. To be eligible for this award, offerors must have experience producing vaccines against influenza and strains with pandemic potential. Mandatory qualifications include either holding a U.S. influenza vaccine license or demonstrating the development of an influenza vaccine through the submission of a Biologics License Application for seasonal or pandemic vaccines. This solicitation is managed by the Department of Health and Human Services with a response deadline of October 30, 2026.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Animal Model Development for Phosphine & Cyanide ExposureThis contract involves the development and validation of animal models designed to accurately replicate human exposure to phosphine and cyanide. These models are intended to be used for testing medical countermeasures under the FDA Animal Rule, which provides regulatory pathways for drugs and biologics when human trials are not ethical or feasible. The work falls under the subcontract category and is associated with the Department of Health and Human Services, specifically managed by BARDA (Biomedical Advanced Research and Development Authority) and affiliated offices. The focus of the effort is to create reliable and scientifically robust animal models that can simulate the toxicological and pharmacological effects of phosphine and cyanide exposure in humans. This will facilitate the evaluation and approval of medical treatments aimed at counteracting these toxic agents in emergency or threat scenarios. The contract aligns with NAICS code 541715, which involves research and development in the physical, engineering, and life sciences sectors. The solicitation was posted in April 2026, and although specific details on location and points of contact are not provided, the contract is accessible through official government procurement platforms.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Expanded Biological Sample Analysis (Toxicology & Biomarkers)The contract involves the comprehensive analysis of biological samples, including blood, serum, and urine, to identify toxicological markers, conduct metabolomic profiling, and gather pharmacokinetic data. This work is aimed at assessing the safety and efficacy of medical countermeasures (MCM), supporting efforts to ensure that these interventions meet required safety standards and perform effectively in relevant scenarios. The contract falls under the NAICS code 541620, which relates to environmental consulting services, indicating specialized scientific and analytical work. Awarded by the Department of Health and Human Services through the Biomedical Advanced Research and Development Authority (BARDA), the subcontract focuses on advanced biological sample analysis as part of ongoing health protection initiatives. Although specific solicitation and contact details are not provided, the contract was posted in April 2026 and is intended to bolster toxicological and biomarker research critical to public health preparedness and response efforts. The work is conducted under the oversight of BARDA programs, underscoring its strategic importance in developing therapeutic and diagnostic solutions.

Environmental Consulting Services

POSTED

DEADLINE

In Vivo Imaging and Data Acquisition (Preclinical)This contract involves conducting in vivo preclinical imaging using modalities such as MRI, CT, and PET to study live animal models during nonclinical investigations. The goal is to evaluate physiological responses to various chemical agents and medical countermeasures, supporting the assessment and development of these substances. The contract is issued as a subcontract under the NAICS code 541380 and is managed by the Department of Health and Human Services through its bureaus including BARDA and ASPR. The contract emphasizes data acquisition and analysis in preclinical settings, playing a critical role in advancing medical research and product development aimed at improving public health preparedness and response. The location details and point of contact information were not specified, but the contract was posted on April 22, 2026, reflecting ongoing efforts to support nonclinical study capabilities in biomedical research.

Testing Laboratories and Services

POSTED

DEADLINE

Tissue Collection, Processing, and HistopathologyThis contract involves the collection, preservation, sectioning, and histological analysis of animal tissues following exposure to chemical agents and medical countermeasures (MCMs). The purpose is to support toxicology and efficacy assessments, ensuring thorough examination of tissue responses to these substances. The scope includes detailed processing and microscopic evaluation to provide critical data for understanding the biological effects and safety profiles of the tested agents. Issued by the Department of Health and Human Services under the BARDA-ASPR/DAAPO/BARDA DCMA umbrella, this subcontract falls under the NAICS code 541611, indicating professional, scientific, and technical services. The contract was posted on April 22, 2026, and although specific location details and points of contact are not provided, it is structured to facilitate specialized laboratory analysis essential for public health preparedness and response initiatives.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Nonclinical Animal Dose Escalation Studies (Schedule 1 Chemicals)This contract involves the execution of nonclinical dose escalation studies using highly hazardous chemical agents, such as phosphine and cyanide, in animal models. The primary goal is to evaluate the efficacy of medical countermeasures under the FDA’s Animal Rule, which allows for drug approval based on animal testing when human trials are not ethical or feasible. The work focuses on Schedule 1 chemicals, requiring strict adherence to safety and regulatory standards due to the high-risk nature of the substances involved. The contract is a subcontract under the Department of Health and Human Services, specifically managed by the Biomedical Advanced Research and Development Authority (BARDA) along with associated offices. It falls under the NAICS code 541714, which covers research and development in biotechnology. While specific details about the location of performance and points of contact are not provided, the contract supports the development of critical medical countermeasures aimed at protecting public health from chemical threats.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Specialized Compliance and Safety ConsultingThis contract involves providing specialized compliance and safety consulting services focused on supporting the use of Select Agents, ensuring adherence to human subjects research protocols under the Institutional Review Board (IRB), maintaining proper animal care standards through the Institutional Animal Care and Use Committee (IACUC), and managing export control compliance. The work falls under NAICS code 541690, indicating professional scientific and technical consulting services, and is structured as a subcontract. The contract is issued by the Department of Health and Human Services, specifically through the Barda - Aspr / Daappo / Barda Dcma office, reflecting its connection to public health and advanced research initiatives. The solicitation was posted in March 2026, with a response deadline set for September 2028, signaling a long-term project timeline. While specific geographic details and points of contact are not provided, the focus on compliance across several critical regulatory areas highlights the importance of expert advisory support to maintain legal and ethical standards in research and safety operations.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

in about 2 years